rs147276580
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6
The NM_000098.3(CPT2):c.1372A>C(p.Lys458Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000164 in 1,614,204 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. K458K) has been classified as Likely benign.
Frequency
Consequence
NM_000098.3 missense
Scores
Clinical Significance
Conservation
Publications
- carnitine palmitoyltransferase II deficiencyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen, Myriad Women’s Health
- carnitine palmitoyl transferase II deficiency, myopathic formInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, PanelApp Australia
- carnitine palmitoyl transferase II deficiency, neonatal formInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), PanelApp Australia
- carnitine palmitoyl transferase II deficiency, severe infantile formInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Orphanet
- encephalopathy, acute, infection-induced, susceptibility to, 4Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| CPT2 | ENST00000371486.4 | c.1372A>C | p.Lys458Gln | missense_variant | Exon 4 of 5 | 1 | NM_000098.3 | ENSP00000360541.3 |
Frequencies
GnomAD3 genomes AF: 0.000802 AC: 122AN: 152204Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000239 AC: 60AN: 251306 AF XY: 0.000199 show subpopulations
GnomAD4 exome AF: 0.0000985 AC: 144AN: 1461882Hom.: 1 Cov.: 34 AF XY: 0.0000908 AC XY: 66AN XY: 727240 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000794 AC: 121AN: 152322Hom.: 0 Cov.: 32 AF XY: 0.000819 AC XY: 61AN XY: 74476 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2
The K458Q variant in the CPT2 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. The K458Q variant is observed in 37/10370 (0.36%) alleles from individuals of African background in the ExAC dataset, and no individuals were reported to be homozygous (Lek et al., 2016). The K458Q variant is a semi-conservative amino acid substitution, which may impact secondary protein structure as these residues differ in some properties. This substitution occurs at a position that is not conserved across species, and in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. We interpret K458Q as a variant of uncertain significance. -
- -
Carnitine palmitoyl transferase II deficiency, severe infantile form Uncertain:1
This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -
Carnitine palmitoyltransferase II deficiency Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at